| Authors: |
Chou DB; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Frismantas V; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Milton Y; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., David R; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Pop-Damkov P; DMPK, Oncology R&D, AstraZeneca, Boston, MA, USA., Ferguson D; DMPK, Oncology R&D, AstraZeneca, Boston, MA, USA., MacDonald A; Clinical and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK., Vargel Bölükbaşı Ö; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Joyce CE; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Moreira Teixeira LS; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Rech A; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Chemical Engineering, Loughborough University, Loughborough, UK., Jiang A; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Calamari E; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Jalili-Firoozinezhad S; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Bioengineering and Institute for Bioengineering and Biosciences (iBB), Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal., Furlong BA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., O'Sullivan LR; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Ng CF; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Choe Y; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Marquez S; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Myers KC; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, OH, USA., Weinberg OK; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Novak R; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Levy O; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Prantil-Baun R; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Novina CD; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Shimamura A; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Ewart L; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ingber DE; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA. don.ingber@wyss.harvard.edu.; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. don.ingber@wyss.harvard.edu.; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA, USA. don.ingber@wyss.harvard.edu. |
